HomeInsightsStock Comparison

Astrazeneca Pharma India Ltd vs Cian Healthcare Ltd Stock Comparison

Astrazeneca Pharma India Ltd vs Cian Healthcare Ltd Stock Comparison

Last Updated on: Jul 22, 2025

Key Highlights

  • The Latest Trading Price of Astrazeneca Pharma India Ltd is ₹ 9110 as of 22 Jul 12:13.
  • The P/E Ratio of Astrazeneca Pharma India Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Cian Healthcare Ltd changed from 562.5 on March 2021 to 206.7 on March 2024 . This represents a CAGR of -22.14% over 4 years.
  • The Market Cap of Astrazeneca Pharma India Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Cian Healthcare Ltd changed from ₹ 35.04 crore on March 2020 to ₹ 51.67 crore on March 2024 . This represents a CAGR of 8.08% over 5 years.
  • The revenue of Astrazeneca Pharma India Ltd for the Mar '25 is ₹ 496.63 crore as compare to the Dec '24 revenue of ₹ 448.27 crore. This represent the growth of 10.79% The revenue of Cian Healthcare Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Astrazeneca Pharma India Ltd for the Mar '25 is ₹ 96.84 crore as compare to the Dec '24 ebitda of ₹ 51.42 crore. This represent the growth of 88.33% The ebitda of Cian Healthcare Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Astrazeneca Pharma India Ltd changed from ₹ 53.86 crore to ₹ 58.25 crore over 8 quarters. This represents a CAGR of 4.00% The net profit of Cian Healthcare Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Astrazeneca Pharma India Ltd changed from 3.46 % on March 2020 to 37.15 % on March 2024 . This represents a CAGR of 60.76% over 5 yearsThe Dividend Payout of Cian Healthcare Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Astrazeneca Pharma India Ltd

  • AstraZeneca Pharma India Limited (APIL) was incorporated on July 11, 1979.
  • The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company.
  • The major therapy areas where the company operates are Onocology, Alimentary & Metabolism, Cardio Vascular, Renal, Diabetes, Respiratory and Oncology. AstraZeneca Pharma India, formerly known as Astra-IDL (AIL), was an erstwhile joint venture of Astra Zeneca, UK and Hinduja controlled IDL. Astra Pharmaceuticals AB, Sweden acquired all of the 1287500 equity shares in the Company of IDL, representing 25.75% of the Company's issued and paid up equity share capital.
  • Consequently, the Company became a subsidiary of Astra, which is a direct wholly owned subsidiary of Astra AB, Sweden (now known as AstraZeneca Pharmaceuticals AB Sweden) and an indirect wholly owned subsidiary of AstraZeneca Plc, the Group parent Company.

About Cian Healthcare Ltd

  • Cian Healthcare Limited was originally incorporated as a Private Limited Company with the name of 'Cian Healthcare Private Limited' on January 07, 2003.
  • Subsequently, the Company was converted into a Public Limited Company and the name of the Company was changed to 'Cian Healthcare Limited' pursuant to a fresh Certificate of Incorporation granted by the Registrar of Companies, Pune dated November 30, 2018. The Company is a WHO-GMP & ISO-9001:2015 certified transnational manufacturing Company with wide range of Pharmaceutical, Nutraceutical, Ayurvedic, Cosmeceuticals, Sexual Wellness and Food supplement products.
  • The Company has a full-fledged F & D and regulatory department.
  • The Company complies with the standard manufacturing practices as laid down by the World Health Organization and is also certified by the Food and Drug Control Administration.

Astrazeneca Pharma India Ltd News Hub

News

AstraZeneca Pharma gets CDSCO approval to import Durvalumab Solution

Through this approval, Durvalumab in combination with carboplatin and paclitaxel is indica...

Read more

02 Jul 2025 10:26

News

Astrazeneca Pharma India Ltd leads losers in 'A' group

Orient Cement Ltd, India Cements Ltd, Concord Biotech Ltd and ERIS Lifesciences Ltd are am...

Read more

20 Jun 2025 15:00

News

AstraZeneca Pharma slides as MD Sanjeev Panchal steps down; Praveen Rao Akkinepally to take charge

Panchal is set to transition to a global role within the AstraZeneca Group, based in Gaith...

Read more

10 Jun 2025 09:49

News

Astrazeneca Pharma India Ltd Spurts 7.28%

Astrazeneca Pharma India Ltd gained 7.28% today to trade at Rs 8545.4. The BSE Healthcare ...

Read more

02 Jun 2025 09:30

News

AstraZeneca Pharma soars after Q4 PAT jumps 48% YoY

Profit before tax (PBT) stood at Rs 78.47 crore in Q4 FY25, up 44.35% year-on-year, and up...

Read more

02 Jun 2025 10:10

News

Volumes soar at Astrazeneca Pharma India Ltd counter

Max Healthcare Institute Ltd, Godrej Consumer Products Ltd, Mphasis Ltd, Indraprastha Gas ...

Read more

02 Jun 2025 11:00

Cian Healthcare Ltd News Hub

News

Cian Healthcare to convene board meeting

Cian Healthcare will hold a meeting of the Board of Directors of the Company on 9 July 202...

Read more

04 Jul 2024 10:16

News

Cian Healthcare schedules board meeting

Cian Healthcare will hold a meeting of the Board of Directors of the Company on 14 June 20...

Read more

10 Jun 2024 10:36

News

Cian Healthcare to conduct board meeting

Cian Healthcare will hold a meeting of the Board of Directors of the Company on 5 June 202...

Read more

03 Jun 2024 10:36

News

Cian Healthcare to hold board meeting

Cian Healthcare will hold a meeting of the Board of Directors of the Company on 30 May 202...

Read more

22 May 2024 17:25

News

Cian Healthcare to convene board meeting

Cian Healthcare will hold a meeting of the Board of Directors of the Company on 14 Novembe...

Read more

08 Nov 2023 12:22

News

Cian Healthcare AGM scheduled

Cian Healthcare announced that the 20th Annual General Meeting (AGM) of the company will b...

Read more

08 Sep 2023 17:27

SWOT Analysis Of Cian Healthcare Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Cian Healthcare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Astrazeneca Pharma India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Astrazeneca Pharma India Ltd and Cian Healthcare Ltd

Which company has a larger market capitalization, Astrazeneca Pharma India Ltd or Cian Healthcare Ltd?

Market cap of Astrazeneca Pharma India Ltd is 22,821 Cr while Market cap of Cian Healthcare Ltd is 9 Cr

What are the key factors driving the stock performance of Astrazeneca Pharma India Ltd and Cian Healthcare Ltd?

The stock performance of Astrazeneca Pharma India Ltd and Cian Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astrazeneca Pharma India Ltd and Cian Healthcare Ltd?

As of July 22, 2025, the Astrazeneca Pharma India Ltd stock price is INR ₹9128.5. On the other hand, Cian Healthcare Ltd stock price is INR ₹3.69.

How do dividend payouts of Astrazeneca Pharma India Ltd and Cian Healthcare Ltd compare?

To compare the dividend payouts of Astrazeneca Pharma India Ltd and Cian Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions